www.bloomberg.com
Summarize this content to 100 words: Pfizer Inc. revealed data from one of its new obesity treatments early Tuesday that had little detail, leaving investors wondering if the pricey acquisition of Metsera Inc. will fill the gaps from its declining Covid shot and pill franchises.
Read More
